Addressing immunization barriers, benefits, and risks

Journal of Family Practice

Volumn 56, Issue SUPPL. 2, 2007, Pages

  Kimmel, Sanford R ^a   Burns, Ilene Timko ^a   Wolfe, Robert M ^a   Zimmerman, Richard Kent ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GELATIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MUMPS VACCINE; NEOMYCIN; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE; SMALLPOX VACCINE; TETANUS TOXOID; THIOMERSAL; VACCINE;

ANAPHYLAXIS; ASTHMA; AUTISM; CHRONIC FATIGUE SYNDROME; CRYING; DELAYED HYPERSENSITIVITY; DIABETES MELLITUS; DISEASE PREDISPOSITION; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; FEBRILE CONVULSION; FEVER; FOOD ALLERGY; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INCIDENCE; INJECTION SITE ABSCESS; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; INSULIN DEPENDENT DIABETES MELLITUS; IRRITABILITY; MULTIPLE SCLEROSIS; MUSCLE HYPOTONIA; PERCEPTION; PHYSICIAN; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW; UNITED STATES;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COMMUNICATION BARRIERS; DISEASE NOTIFICATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; IMMUNOTHERAPY, ACTIVE; INFANT; INFANT, NEWBORN; MALE; PARENT-CHILD RELATIONS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; REMINDER SYSTEMS; RISK ASSESSMENT; UNITED STATES; VACCINES;

EID: 33847128848     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Centers for Disease Control and Prevention. Summary of notifiable diseases-United States, 2002. April 30, 2004 for MMWR Morb Mortal Wkly Rep. 2002;51:5, 10, 76.
2. Centers for Disease Control and Prevention. Notice to readers: final 2004 reports of notifiable diseases. MMWR Morb Mortal Wkly Rep. 2005;54:770.
3. Cherry JD. The science and fiction of the "resurgence" of pertussis. Pediatrics. 2003;112:405-406.
4. Centers for Disease Control and Prevention. National, state, and urban area vaccination coverage among children aged 19-35 months-United States, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:988-993.
5. Centers for Disease Control and Prevention. Immunization and Infectious Diseases. In US Department of Health and Human Services. Healthy People 2010, 2nd ed. Understanding and Improving Health and Objectives for Improving Health. 2 vols. Washington, DC: US Government Printing Office: November 2000:14-1, 14-59.
6. Gore P, Madhavan S, Curry D, et al. Predictors of childhood immunization completion in a rural population. Soc Sci Med. 1999;48:1011-1027.
7. Centers for Disease Control and Prevention. Notice to readers: limited supply of meningococcal conjugate vaccine, recommendation to defer vaccination of persons aged 11-12 years. MMWR Mortal Wkly Rep. 2006;55:567-568. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5520a11.htm. Accessed January 11, 2007.
8. Prislin R, Sawyer MH, Nader PR, Goerlitz M, De Guire M, Ho S. Provider-staff discrepancies in reported immunization knowledge and practices. Prev Med. 2002;34:554-561.
9. Madlon-Kay D, Harper PG. Too many shots? Parent, nurse, and physician attitudes toward multiple simultaneous childhood vaccinations. Arch Fam Med 1994;3:610-613.
10. Melman ST, Nguyen TT, Ehrlich E, Schorr M, Anbar RD. Parental compliance with multiple immunization injections. Arch Pediatr Adolesc Med. 1999;153:1289-1291.
11. Tierney CD, Yusuf H, McMahon SR, et al. Adoption of reminder and recall messages for immunizations by pediatricians and public health clinics. Pediatrics. 2003;112:1076-1082.
12. Schaffer SJ, Humiston SG, Shone LP, Averhoff FM, Szilagyi PG. Adolescent immunization practices: a national survey of US physicians. Arch Pediatr Adolesc Med. 2001;155:566-571.
13. Brenner RA, Simons-Morton BG, Bhaskar B, Das A, Clemens JD; NIH-DC Initiative Immunization Working Group. Prevalence and predictors of immunization among inner-city infants: a birth cohort study. Pediatrics. 2001;108:661-670.
14. Zimmerman RK, Santibanez TA, Janosky JE, et al. What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and Veterans Affairs practices. Am J Med. 2003;114:31-38.
15. Smailbegovic MS, Laing GJ, Bedford H. Why do parents decide against immunization? The effect of health beliefs and health professionals. Child Care Health Dev. 2003;29:303-311.
16. Prislin R, Dyer JA, Blakely CH, Johnson CD. Immunization status and sociodemographic characteristics: the mediating role of beliefs, attitudes, and perceived control. Am J Public Health. 1998;88:1821-1826.
17. Centers for Disease Control and Prevention. Immunization registry progress-Unired States, January-December 2002. MMWR Morb Mortal Wkly Rep. 2004;53:431-433.
18. Adams WG, Conners WP, Mann AM, Palfrey S. Immunization entry at the point of service improves quality, saves time, and is well-accepted. Pediatrics. 2000;106:489-492.
19. Glazner JE, Beaty BL, Pearson KA, Lowery NE, Berman S. Using an immunization registry: effect on practice costs and time. Ambul Pediatr. 2004;4:34-40.
20. Centers for Disease Control and Prevention. Vaccine-preventable diseases: improving vaccination coverage in children, adolescents and adults. A report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep. 1999;48(RR-8):1-15.
21. Zimmerman RK, Nowalk MP, Raymund M, et al. Tailored interventions to increase influenza vaccination in neighborhood health centers serving the disadvantaged. Am J Public Health. 2003;93:1699-1705.
22. Wolfe RM, Sharp LK, Lipsky MS. Content and design attributes of antivaccination web sites. JAMA. 2002;287:3245-3248.
23. Kimmel SR, Puczynski S, McCoy RC, Puczynski MS. Practices of family physicians and pediatricians in administering poliovirus vaccine. J Fam Pract. 1999;48:594-600.
24. Chen RT, Hibbs B. Vaccine safety: current and future challenges. Pediatr Ann. 1998;27:445-455.
25. Gust DA, Strine TW, Maurice E, et al. Underimmunization among children: effects of vaccine safety concerns on immunization status. Pediatrics. 2004;114:e16-e22.
26. Freed GL, Clark SJ, Hibbs BF, Santoli JM. Parental vaccine safety concerns. The experiences of pediatricians and family physicians. Am J Prev Med. 2004;26:11-14.
27. Freeman TR, Bass MJ. Determinants of maternal tolerance of vaccine-related risks. Fam Pract. 1992;9:36-41.
28. Gellin BG, Maibach EW, Marcuse EK. Do parents understand immunizations? A national telephone survey. Pediatrics. 2000;106:1097-1102.
29. Zimmennan RK, Wolfe RM, Fox DE, et al. Vaccine criticism on the world wide web. J Med internet Res. 2005;7:e17 Available at: www.jmir.org/2005/2/e17/. Accessed July 12, 2005.
30. Ball LK, Evans G, Bostrorn A. Risky business: challenges in vaccine risk communication. Pediatrics. 1998;101:453-458.
31. Meszaros JR, Asch DA, Baron J, Hershey JC, Kunreuther H, Schwartz-Buzaglo J. Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. J Clin Epidemiol. 1996;49:697-703.
32. Offit PA, Quarles J, Gerber MA, et al. Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics. 2002;109:124-129.
33. Pickering LD, ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2003:4-7, 37-53, 318-336, 419-429, 439-443, 536-541, 672-686.
34. Davis TC, Fredrickson DD, Arnold CL, et al. Childhood vaccine risk/benefit communication in private practice office settings: a national survey. Pediatrics. 2001;107:E17.
35. Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA. 2000;284:3145-3150.
36. Advisory Committee on Immunization Practices. Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACTP). MMWR Recomm Rep. 2000;49(RR-13):1-8.
37. Zimmerman RK, Ruben FL, Ahwesh ER. Hepatitis B virus infection, hepatitis B vaccine, and hepatitis B immune globulin. J Fam Pract. 1997;45:295-318.
38. Advisory Committee on Immunization Practices. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-7):1-25.
39. Maldonado Y. Measles. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed. Philadelphia, Pa: WB Saunders Co; 2004:1026-1031.
40. Maldonado Y. Mumps. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed. Philadelphia, Pa: WB Saunders Co; 2004:1035-1036.
41. Maldonado Y. Rubella. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed. Philadelphia, Pa: WB Saunders Co; 2004:1032-1034.
42. Centers for Disease Control and Prevention. Table 2. Reported cases of notifiable diseases, by geographic division and area-United States, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:883-903.
43. Gershon A. Rubella virus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000:1708-1714.
44. Patja A, Davidkin I, Kurki T, Kallio MJT, Valle M, Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J. 2000;19:1127-1134.
45. Baum SG, Litman N. Mumps virus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000:1776-1781.
46. Markowitz LE, Katz SL. Measles vaccine. In: Plotkin AS, Mortimer EA, Jr, eds. Vaccines. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1994:229-276.
47. Advisory Committee on Immunization Practices. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1996;45(RR-11):1-36.
48. Wise RP, Salive ME, Braun MM, et al. Postlicensure safety surveillance for varicella vaccine. JAMA. 2000;284:1271-1279.
49. Laupland KB, Davies HD, Low DE, Schwartz B, Green K, The Ontario Group A Streptococcal Study Group, McGeer A. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Pediatrics. 2000;105:e60.
50. Myers MG, Stanberry LR, Seward JF. Varicella-zoster virus. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed. Philadelphia, Pa: WB Saunders Co; 2004:1057-1062.
51. Whiteley RJ. Varicella-zoster virus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infections Diseases. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000:1580-1586.
52. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351:637-641.
53. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999;353:2026-2029.
54. Madsen KM. Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002;347:1477-1482.
55. Fisher BL, ed. Hepatitis B vaccine: the untold story. The Vaccine Reaction. Vienna, Va: National Vaccine Information Center; 1998:1-15.
56. Ascherio A, Zhang SM, Hernán MA, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med. 2001;344:327-332.
57. Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med. 2001;344:319-326.
58. The Institute for Vaccine Safety Diabetes Workshop Panel. Childhood immunizations and type 1 diabetes: summary of an Institute for Vaccine Safety Workshop. Pediatr Infect Dis J 1999;18:217-222.
59. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Childhood vaccination and type 1 diabetes. N Engl J Med 2004;350:1398-1404.
60. Blom L, Nyström L, Dahlquist G. The Swedish childhood diabetes study: vaccination and infections as risk determinants for diabetes in childhood. Diabetologia. 1991;34:176-181.
61. DeStefano F, Mullooly JP, Okoro CA, et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics. 2001;108:e112.
62. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal-containing vaccine and autism. JAMA. 2003;290;1763-1766.
63. Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D. Autism and thimerosal-containing vaccines. Lack of consistent evidence for an association. Am J Prev Med. 2003;25:101-106.
64. Institute of Medicine Immunization Safety Review Committee, McCormick MC (Chair). Immunization Safety Review. Vaccines and Autism. Washington, DC: National Academies Press; 2004:1-20.